- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 25/24 - Antidepressants
Patent holdings for IPC class A61P 25/24
Total number of patents in this class: 4767
10-year publication summary
|
164
|
245
|
297
|
314
|
374
|
418
|
487
|
433
|
407
|
268
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Antecip Bioventures II LLC | 386 |
98 |
| GH Research Ireland Limited | 90 |
67 |
| Takeda Pharmaceutical Company Limited | 2700 |
66 |
| Janssen Pharmaceutica N.V. | 3147 |
64 |
| F. Hoffmann-La Roche AG | 7798 |
53 |
| Hoffmann-La Roche Inc. | 3841 |
41 |
| Taisho Pharmaceutical Co., Ltd. | 846 |
41 |
| Janssen Pharmaceuticals, Inc. | 430 |
39 |
| Sage Therapeutics, Inc. | 210 |
37 |
| Intra-Cellular Therapies, Inc. | 439 |
36 |
| H. Lundbeck A/S | 1237 |
31 |
| Alto Neuroscience, Inc. | 83 |
29 |
| Shanghai Institute of Materia Medica, Chinese Academy of Sciences | 877 |
28 |
| Xenon Pharmaceuticals Inc. | 194 |
28 |
| The Trustees of Columbia University in the City of New York | 3652 |
27 |
| Sumitomo Dainippon Pharma Co., Ltd. | 210 |
27 |
| Gilgamesh Pharmaceuticals, Inc. | 66 |
27 |
| Sage Therapeutics, LLC | 163 |
27 |
| Compass Pathfinder Limited | 122 |
25 |
| The Regents of the University of California | 20902 |
24 |
| Other owners | 3952 |